Merck Company Essay

4630 words - 19 pages

Merck & Company Inc.
MERCK & COMPANY INCKady DoyleRudy HsiehEunkyung JunJoey PetrellaMastura ZainiTable of Contents 2Overview of Merck & Co Inc. 3Case Abstract 4History 5Timeline of Important Milestones 5Vision Statement 7Mission Statement 7Opportunities 9Threats 9External Factor Evaluation (EFE) Matrix 9CPM 11Internal Audit 12Strengths 13Weaknesses 13Financial Ratio Analysis 13Company and Industry Performance 14Internal Factor Evaluation (IFE) Matrix 17SWOT Matrix 18SPACE Matrix 21Grand Strategy Matrix 24The Internal-External (IE) Matrix 26Balanced Score Card (Figure 1) 28Balanced Scorecard 28Benchmarking 28Outsourcing 29QSPM 31Recommendations 33EPS / EBIT Analysis 36Epilogue 37Overview of Merck & Co Inc.Case AbstractMerck and Company Inc. was incorporated in New Jersey and trades on the New York Stock Exchange (NYSE: MRK). It is a research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of products used to improve consumer and animal health, generating sales of $27.4 billion with an operating profit of $2.4 billion as December 31, 2009.Headquartered in Whitehouse Station, N.J., Merck provides its products through wholesale, retail drug and food chain, and mass merchandiser outlets in the United States and worldwide. In addition, the company has production facilities for its human health products at locations in the United States, Puerto Rico, as well as plants in Australia, Canada, Japan, Singapore, South Africa and other countries in Western Europe, Central and South America, and Asia.The company operates in three segments: the pharmaceutical, animal health and consumer healthcare segments. The Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in various areas across the body. The Animal Health segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fishes. The Consumer Health Care segment provides over-the-counter products, including antihistamines, products for constipation, cold/flu medicines, nasal decongestant sprays, and laxative tablets among others. Among Merck's major brands are Singulair, Fosamax, Zocor, Gardasil and Varivax.In its drug manufacturer industry, Merck's major competitors are Johnson & Johnson, Pfizer, Novartis, GlaxoSmithKline as well as other smaller companies. In terms of market capitalization, Johnson & Johnson leads the industry at $162.9 billion, while Merck ranks 4th at $106.7 billionBased on analysis of Merck's dividend growth rate the stock is priced above its valuation. However, due to concerns about Merck's drug pipeline, revenue growth, and generic competition already being reflected in its current stock price, the stock is rated a hold. Further, Merck's low P/E and attractive yield relative to the...

Find Another Essay On merck company

You decide Essay

2890 words - 12 pages You Decide- Medco and Merck MergerRecommendations are being prepared to be present to the board of directors regarding Merck's acquisition of Medco. I have gathered information form several key employees within the organization in order to determine whether the merger will be profitable and allow the company continued growth. This analysis will include supporting calculations regarding the two companies becoming one. |Ladies and gentlemen I have

merck Essay

4630 words - 19 pages Merck & Company Inc. MERCK & COMPANY INCKady DoyleRudy HsiehEunkyung JunJoey PetrellaMastura ZainiTable of Contents 2Overview of Merck & Co Inc. 3Case Abstract 4History 5Timeline of Important Milestones 5Vision Statement 7Mission Statement 7Opportunities 9Threats 9External Factor Evaluation (EFE) Matrix 9CPM 11Internal Audit 12Strengths 13Weaknesses 13Financial Ratio Analysis 13Company and Industry Performance 14Internal Factor

The Vioxx Recall - Merck and FDA

2853 words - 11 pages The Central Problem In the Merck, the FDA, and the Vioxx Recall case study, the question as to whether or not Merck conducted itself in a socially responsible and ethical manner with regard to Vioxx is the central problem we will examine in this case. Many argue that the sole problem lies within the pharmaceutical company Merck and Co., Inc., and while that may in fact be the case, other parties such as the Food and Drug Administration (FDA

Merck and Vioxx, the implications of new product development in the pharmaceutical industry

2228 words - 9 pages industry whereby a pharmacologist in a competing firm had developed a pain killer that is gentle on the stomach; internal mandates whereby a lab test was developed to determine the amount of stomach upset caused by painkillers; new resources, as an non-irritating painkiller formula by another company which had not yet underwent human testing.After the opportunities were identified, Merck moved onto the concept generation phase, whereby the product

Whether a Cut in Corp Tax Rate be Beneficial

4338 words - 17 pages . However, these two companies differ in as many aspects as they do compare. First, Ford Motor Company is based in a consumer demand industry. If the demand for automobiles, etc., they will have to cut production, thus cutting into sales and revenue. Merck & Co., on the other hand, has more predictability as far as sales. Pharmaceuticals are, for the most part, necessary in peoples’ lives. Due to this feature, Merck & Co. is a more defensive

Business Ethics and the Merck & Co., Inc. Case Study

2754 words - 11 pages Susan GustafsonBusiness EthicsMark Matthews, Ph.D.February 10, 2004Applying Ethics to the Merck CaseThe purpose of my essay is to show whether the business decisions made by the management team of Merck pharmaceutical are ethical. Using corporate assets for charitable purposes, the company manufactures and distributes a drug called Mectizan at no charge to impoverished nations and their inhabitants.I will expound on three ethical theories and

brazil leading the BRICS case study

1334 words - 5 pages company in 2005. Over the course of 16 official meetings, Merck lowered its price again to $570 per patient per year. Brazilian health and trade officials demanded better, citing generic suppliers ready to provide the drug at $240 per patient per year.Brazil ignored Merk's multiyear staged technology transfer to Farmanguinhos.To protect its IP, Merck proposed a multiyear staged technology transfer for efavirenz to Farmanguinhos, Brazil's national

brazil leading the BRICS case study

1334 words - 5 pages company in 2005. Over the course of 16 official meetings, Merck lowered its price again to $570 per patient per year. Brazilian health and trade officials demanded better, citing generic suppliers ready to provide the drug at $240 per patient per year.Brazil ignored Merk's multiyear staged technology transfer to Farmanguinhos.To protect its IP, Merck proposed a multiyear staged technology transfer for efavirenz to Farmanguinhos, Brazil's national

malek

1237 words - 5 pages Krumholz, H., Hines,H., Ross, J., Presler, A., Egilman, D. (2007 January 20) What have we learned from Vioxx? BMJ, 334(7585). Retrieved November 11, 2013 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779871/ In this article several professors talk about the Vioxx story. They talk about how data was falsified or not included to hide the cardiovascular effects of Vioxx. This article talks about how such a respected company such as Merck can

Cervical Cancer and The HPV Vaccine Controversy: Where are the men? Where is the money?

1800 words - 7 pages , Merck, lobbied legislators to make the vaccine mandatory. From widespread vaccine administration the manufacturer stands to profit greatly. As a result, “it is inappropriate for the company to finance efforts to persuade states and public officials to make HPV vaccinations mandatory, particularly so soon after the product was licensed. Private wealth should never trump public health” (Gostin and DeAngelis 2007, 1). Objecting to legislating

SWOT Analysis: Pfizer

1025 words - 4 pages Unfortunately no matter how well a company may be their will also are threats. Threats to Pfizer would have to be its competition. A few of Pfizer’s competitors are Bayer AG and Merck & Co Inc. Bayer AG known in the US as Bayer Corporation is the company that created aspirin in 1897. Bayer also makes health care products, specialty products such as plastics and high performance materials and several agricultural products for crops and home

Similar Essays

Merck's Case Ethical Essay

1847 words - 7 pages human care, are they ethically obligated to pass the information about the drug on if another company wishes to pursue it, even though it may be risky for any plans they have for animal care. Ethical Principles Applicable: The Deontological theory could be applied in this situation, because determining what the duties and obligations of pharmaceutical companies, like Merck, are could help determine whether they are obliged to do the

Fda's Approval Of Prescription Drugs Essay

1537 words - 6 pages administration) and the drug producing company Merck. The FDA tests all drugs and gives the approval for them to be used by the general public. Merck and co is a drug producing company based in Whitehouse, N.J. Merck creates the drugs and has them tested by the FDA for the approval. Merck is also the world's fifth largest pharmaceutical firm. Merck is best known for producing drugs such as Singular for Asthma and seasonal Allergic rhinitis

Vioxx And Merck & Co. Essay

582 words - 2 pages connected with Merck & Co., they would obviously vote in a way that would support the company, and in turn, benefit themselves. It seems that the value of the well being of the patients that use this medication is being neglected while the Merck and its associates simply look out for themselves.      I do not believe that Vioxx should be put back on the market. For one thing, it has already become clear how detrimental its

Case Study Merck & Co Make Sure You Label Graphs & Tables, Abstract Should Be Around 300 Words

2303 words - 9 pages AbstractLeading up to the year 2000, Merck & Co., Inc. had gained success in the pharmaceutical industry with drugs like Vasotec, for help with blood pressure ("Vasotec," 2013), and Pepcid, to relieve issues with stomach acid ("Pepcid complete," 2013). Merck had generate about $5.7 billion through the sales of their more popular drugs, however, the company fears that sales will decline as "generic substitutes become available." Looking to